Lincoln Pharmaceuticals Ltd
Company Profile
Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
INDT: +91 7941078000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,853
Stocks News & Analysis
stocks
The SpaceX IPO and the Elon Musk factor
stocks
The ASX’s most shorted stocks in 2026
stocks
ASX energy producers: Energy prices rise sharply as global tensions flare, but long-term view unchanged
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,637.00 | 18.30 | -0.21% |
| CAC 40 | 7,701.95 | 67.36 | -0.87% |
| DAX 40 | 22,300.75 | 312.22 | -1.38% |
| Dow JONES (US) | 45,166.64 | 793.47 | -1.73% |
| FTSE 100 | 9,967.35 | 4.82 | -0.05% |
| HKSE | 24,727.84 | 224.04 | -0.90% |
| NASDAQ | 20,948.36 | 459.72 | -2.15% |
| Nikkei 225 | 51,610.26 | 1,762.81 | -3.30% |
| NZX 50 Index | 12,748.92 | 186.47 | -1.44% |
| S&P 500 | 6,368.85 | 108.31 | -1.67% |
| S&P/ASX 200 | 8,442.50 | 18.40 | -0.22% |
| SSE Composite Index | 3,922.72 | 9.00 | 0.23% |